← Eichor
Condition: Hematopoietic Stem Cell Mobilization Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hematopoietic Stem Cell Mobilization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apheresis of Patients With Immunodeficiency
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01212055SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Phase 1 · 3 location(s) · St. Jude Children's Research Hospital · NCT06442761Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Phase 3 · 17 location(s) · The Affiliated People's Hospital of Ningbo University · NCT06520163Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Phase 3 · 2 location(s) · Guangzhou Gloria Biosciences Co., Ltd. · NCT06514508Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Thomas Jefferson University · NCT07188090Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilizat
EARLY_Phase 1 · 2 location(s) · Rutgers, The State University of New Jersey · NCT04211259Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
Phase 1 · 1 location(s) · Beijing 302 Hospital · NCT07297173Loratadine for the Prevention of G-CSF-related Bone Pain
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05421416Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma
Phase 2 · 7 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05294055Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injecti
Phase 4 · 1 location(s) · Emory University · NCT07101445Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Phase 3 · 16 location(s) · The Affiliated People's Hospital of Ningbo University · NCT06520176Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Us
Phase 2 · 2 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT01174108Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
Phase 2 · 2 location(s) · IRCCS San Raffaele · NCT03055247Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Partic
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06414889G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
Phase 2 · 3 location(s) · Fudan University · NCT07362810Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT05432310Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
Phase 3 · 8 location(s) · First Affiliated Hospital of Zhejiang University · NCT07692841Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02015013
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.